SPL23 ASO
Alternative Names: SPL23-2; SPL23-ASOLatest Information Update: 28 Jun 2023
Price :
$50 *
At a glance
- Originator SpliSense
- Class Antifibrotics; Antisense oligonucleotides
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator expression modulators; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cystic fibrosis